Video market report
January 30 2020
January 23 2020
January 23 2020
Tablet tst
January 09 2020
analyst interview 1
December 16 2019


Investor Update: ImmuPharma lands licensing deal for Lupuzor

Headlines from the Proactive UK newsroom. ImmuPharma (LON:IMM) has signed an exclusive licence and development agreement with Avion Pharmaceuticals for its Lupus treatment Lupuzor.  Avion will fund a new international Phase III trial up to a cost of US$25mln and commercialise the...

on 28/11/19

Proactive news

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.